Biotech

All Articles

Biogen's chief executive officer stated no dangerous sell 2023. He's ready to be daring

.While Biogen's pharma peers are actually seeking for late-stage assets with little bit of danger, C...

Instil refills pipe in $2B biobucks manage ImmunOnco

.Instil Biography has been actually a biotech looking for a pipeline after it ditched its own lead p...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually returned rights to a very early Alzheimer's ailment course to Denali Therapies,...

Takeda touches brand-new head of US oncology service-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of notable leadership hirings, firings and also...

Vertex, hammered by AATD again, drops 2 resources on throw away pile

.Vertex's attempt to manage an uncommon genetic disease has actually reached another drawback. The b...

Vir gains 3 T-cell engagers from Sanofi, lays off 25% of team

.Vir Biotechnology's second-quarter profits record wasn't short of major news. The company invited a...

Galapagos pauses CAR-T cell therapy litigation over Parkinsonism scenario

.Galapagos has actually paused registration in a test of a BCMA-directed CAR-T cell treatment, pumpi...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After more than thirty years, gene treatment pioneer James Wilson M.D., Ph.D., is actually leaving ...

3 biotechs try to trump the summertime warm through shedding staff

.As biotechs attempt to turn a new page in August, at the very least 3 companies have lost staff in ...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Professional equity capital firm venBio has raised another half a billion dollars to buy biotechs d...